Atlas Trials

Oligoastrocytoma

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Oligoastrocytoma

RecordFirmDate
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931)M.D. Anderson Cancer Center2020-01-30
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma (NCT03180502)NRG Oncology2018-01-23
NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma (NCT03353896)University of Southern California2017-12-15
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved (NCT02530320)Grupo Español de Investigación en Neurooncología2015-10-25
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas (NCT02209428)Huashan Hospital2014-06-01
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952)Dartmouth-Hitchcock Medical Center2013-10-09
(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas (NCT01281982)National Cancer Institute (NCI)2011-01-13
HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas (NCT00874861)Ian F. Pollack, M.D.2009-04-01
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma (NCT01089244)Ludwig-Maximilians - University of Munich2008-06-01
Treatment Strategy for Low-grade Gliomas (NCT00897377)Sun Yat-sen University2007-12-01
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma (NCT00389090)Keryx / AOI Pharmaceuticals, Inc.2006-10-01
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors (NCT00303849)OHSU Knight Cancer Institute2005-09-15
IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma (NCT00089427)INSYS Therapeutics Inc2004-07-01
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide (NCT00717210)Neuro-Oncology Working Group of the German Cancer Society1999-06-01

Track Oligoastrocytoma automatically

Every clearance here is in the API, with alerts when new ones post.